Skip to main content
ConductScienceScienceDex

Xiaoqi Liu

NIH Rank #4583
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8042648Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2024

Linked Award Amount
$2.2M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#4,583
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Xiaoqi Liu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Xiaoqi Liu as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA272483-02R01
    Targeting the Plk1/Pdcd4/mTORC2 Signaling to Treat Castration-Resistant Prostate Cancer
    University of Kentucky
    $601.3K
    award amount
  • 5R01CA264652-04R01
    Plk1 as a prognostic biomarker for prostate cancer
    University of Kentucky
    $520.6K
    award amount
  • 5R01CA256893-04R01
    Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
    University of Kentucky
    $470.3K
    award amount
  • 5R01CA196634-10R01
    Improving chemotherapy of castration-resistant prostate cancer.
    University of Kentucky
    $317.6K
    award amount
  • 5R01CA157429-11R01
    Overcoming Drug Resistance of Castration-Resistant Prostate Cancer
    University of Kentucky
    $275K
    award amount

Award organization

Organizations that administered FY2024 awards listing Xiaoqi Liu as a PI.

FY2024 award administered by University of Kentucky (KY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Kentucky
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4583
  6. 2024
    Entered Top 25% Nationally
    Ranked #4583
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Xiaoqi Liu.

Hsin-sheng Yang
University of Kentucky
3
shared awards

Explore further

Find collaborators for Xiaoqi Liu

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →